Safe Orthopaedics Expands to Germany, Names Jochen Esser Head of Sales
Elizabeth Hofheinz, M.P.H., M.Ed. • Wed, March 15th, 2017
Paris-based Safe Orthopaedics has announced that it is expanding into Germany and has appointed Jochen Esser as Head of Sales Germany.
According to the March 6, 2017 news release, “Jochen has over 25 years’ sales development and sales force leadership experience in the spinal surgery sector, both in Germany and in international markets. Before joining Safe Orthopaedics, Jochen held various sales positions with Zimmer, and DePuy Synthes, the Johnson & Johnson group subsidiary specialized in medical devices, where he was awarded for his sales performance on several occasions. In 2010, he joined K2M, a leader in minimally invasive techniques for back surgery, as head of the Germany, Austria and Switzerland region where he built a team of seven sales representatives and more than tripled the sales base. Since 2015, Jochen has been head of sales Germany at Joimax, a specialist in endoscopic solutions for minimally invasive back surgeries. In this role, he also built up the company’s sales in Austria and Switzerland.”
“We are delighted to welcome Jochen to Safe Orthopaedics. His knowledge of the German market and many years of experience in the spinal surgery sector will be invaluable to our development in Germany where we intend to replicate the success we have had in France with direct sales of our products”, said Pierre Dumouchel, chief executive officer of Safe Orthopaedics. “2017 is shaping up to be a strategically important year for the Group, with the progressive strengthening of our sales force in regions experiencing the most rapid growth. Following on from the appointment of Dr. Franke, a highly renowned German surgeon, to our Scientific Advisory Board, the addition of Jochen as our Head of Sales represents another step forward establishing us in this very important market.”
Jochen Esser added, “I’m very excited to be joining Safe Orthopaedics’ team and to be contributing to its development, following on from its solid performance in 2016. With its steadily growing international footprint and its unrelenting commitment to innovation, Safe Orthopaedics is a breakthrough force in back surgery. Its single-use technology is particularly well-suited for minimally-invasive techniques and for trauma surgeries. With this in mind, I will initially focus on traumatology to establish our sales base in Germany in this key segment before building a larger sales team and catering to the degenerative condition segment.”
Asked why this was the right time to expand into Germany, Pierre Dumouchel commented to OTW, “The German market has been analyzed during several months, especially for trauma business at the first stage. The Safe Orthopaedics technologies (cemented screw, MIS [minimally invasive surgery] technology) responds perfectly to the German surgeons needs. In the same time, the hospitals (80% managed by buying group) are looking for improved efficiency and are really interested by our single use technology that is cancelling 80% of the surgery logistics (study performed with CHU Bicêtre, a leading French teaching hospital), and the cost associated.”
“Mr. Esser is very experienced. His knowledge of the German market and his connection with surgeons will help Safe Orthopaedics to build a strong and strategic sales plan in Germany.”